#news #spacebasedresearch #stem | LambdaVision, Inc.
Summary
LambdaVision has closed a funding round backed by Seven Seven Six, Aurelia Foundry, Seraphim Space, E2MC, and Boryung. The company will use the capital to advance space-based biomanufacturing and move its protein-based artificial retina closer to clinical trials. Its CEO will discuss the sector’s funding challenges at the 2025 Payload Investor Summit. The company says this support validates the potential of space-based research for developing therapies on Earth.
Funding
Amount
$7.0M
Total raised
Date
November 5, 2025
Announcement date
Investors
Boryung Pharmaceutical
Lead investors
Company
http://www.lambdavision.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected
Linked Companies
Refresh Inc.
$1M to $5M